Technology | Clinical Decision Support | March 16, 2017

IBM Watson Health to Integrate MedyMatch Technology into Cognitive Imaging Offerings

MedyMatch application to help doctors identify head trauma and stroke

March 16, 2017 — MedyMatch Technology announced a collaboration with IBM  Watson Health to bring MedyMatch’s artificial intelligence (AI)-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings. In this application, the technology can help doctors identify instances of intracranial bleeding as a result of head trauma and stroke.

Initially, IBM Watson Health’s Imaging group will distribute the MedyMatch brain bleed detection application globally through its vendor neutral sales channels. Moving forward, IBM Watson Health and MedyMatch will develop interoperability between MedyMatch’s application and IBM Watson Health Imaging’s offerings.

According to the American Heart Association and American Stroke Association (AHA/ASA), stroke is the fourth leading cause of death and one of the top causes of preventable disability in the United States. Affecting 4 percent of U.S. adults, it is forecasted that by 2030, there will be approximately 3.4 million stroke victims annually in the U.S., costing the healthcare system $240 billion on an annual basis.

MedyMatch aims to bring cognitive tools into the daily workflow of an emergency department to help physicians assess patients suspected of head trauma or stroke, and rule out the presence of a bleed in the brain. The MedyMatch algorithm uses sophisticated deep learning, machine vision, patient data and clinical insights to automatically highlight for a physician regions of interest that could indicate the potential presence of cerebral bleeds — and does so without interrupting how a physician works.   

“The implementation of AI-based computer-aided detection and clinical decision support tools to medicine in general, and to the emergency department in particular, has the potential to increase the speed, accuracy and efficiency of patient management – with the potential to ultimately reduce diagnostic errors and improving clinical outcomes,” said Michael Lev, M.D., director of emergency radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School.  “MedyMatch is ideally positioned to leverage this technology, and their willingness to collaborate with industry partners reflects their awareness of, and sensitivity to, the complexities of patient assessment in the acute care setting.  The company’s first algorithms — CT [computed tomography] detection of intracranial bleeds — represents the confluence of physician know-how and artificial intelligence clinical support.”

MedyMatch is currently conducting a clinical trial for its intracranial bleed assessment application and is working towards a PMA (premarket approval) Class III approval by the U.S. Food and Drug Administration (FDA).

For more information: www.medymatch.com, www.ibm.com/watsonhealth

Related Content

Toshiba Medical Introduces Aquilion Prime SP CT System at RSNA 2017
Technology | Computed Tomography (CT) | December 13, 2017
Toshiba Medical, a Canon Group company, introduced its new Aquilion Prime SP computed tomography (CT) system at the...
Philips IntelliSpace Portal 10 Highlighted by New 3-D Modeling Application
Technology | Advanced Visualization | December 13, 2017
Philips announced the debut of IntelliSpace Portal 10, the latest edition of its comprehensive, advanced visualization...
Sponsored Content | Videos | Magnetic Resonance Imaging (MRI) | December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
AI Visualize Inc. Debuts Artificial Intelligence Cloud Image Visualization Platform at RSNA 2017
Technology | Remote Viewing Systems | December 13, 2017
AI Visualize Inc. debuted its new cloud-based artificial intelligence (A.I.) -based image analysis and viewing platform...
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI) | December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Sponsored Content | Videos | Cybersecurity | December 12, 2017
J.
Brainlab Contrast Clearance Analysis Software Receives FDA 510(k) Clearance
Technology | Contrast Media | December 12, 2017
Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance Analysis methodology,...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient

MRI of the brain performed on the Galan 3T utilizing the 32-channel Head SPEEDER Coil

Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Sectra Offers Gadolinium Tracking Functionality in DoseTrack Software
Technology | Contrast Media | December 11, 2017
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring s
Philips Debuts IQon Elite Spectral CT Scanner at RSNA 2017
Technology | Computed Tomography (CT) | December 11, 2017
At the 2017 Radiological Society of North America (RSNA) Annual Meeting, Philips unveiled the IQon Elite Spectral CT,...
Overlay Init